With no difference in death or MI, Kevin Bainey says doctors can give medical therapy a good try before sending patients for ...

Clinicians who use the tool more often are less likely to order diagnostic tests and GDMT, even for HFrEF patients.

Though the trial demonstrates the feasibility of the approach, future research is needed to assess the clinical impact.

With COVID now out of the top 5, stroke has taken over the number 4 position thanks to rising death rates in young and old.

The dual approach, though rare, was linked to fewer 2-year MACE and lower long-term costs compared with angiography alone.

Cardio-oncologists should incorporate vascular prevention in their care, especially for those without protective hormones.

For example, in the CTO setting, “IVUS can facilitate proximal cap puncture, subintimal navigation, and reentry, whereas OCT ...

Taking into account estimated 30-year risk of atherosclerotic cardiovascular disease (ASCVD) enables clinicians to identify ...

The risks of in-hospital complications and mortality at 30 days were significantly higher in patients with severe aortic ...

The results make the case that it isn’t prudent to lump various Asian ethnicities together when trying to gauge care quality.

This month: cuffless BP issues in practice, women and lifetime CVD risk, targeting kids for early education, and more.

The initiation of patient enrolment in the STARS DAPT trial marks an important milestone for Abluminus np. While contemporary ...